Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world.
The testing and counseling of persons at risk for infection with HIV and their subsequent treatment remains the primary tool to curb worldwide transmission of the virus. Rapid HIV tests address the need in the developing world for accurate, easy-to-use tests that do not require laboratory equipment or highly trained professionals for implementation or refrigeration for storage. Calypte Biomedical has recently developed the Calypte AWARE HIV-1/2 OMT antibody test using oral fluid samples. This test has demonstrated high sensitivity and specificity for specimens collected in target areas where increased testing is needed. The inexpensive dipstick format in combination with the use of an alternative fluid to blood provides an improved testing procedure for areas with limited resources.
Gottfried
Toby D
TD
Technology Consultant, Orinda, CA 94563, USA. tgottfried@calypte.com
Mink
Ronald W
RW
Phanuphak
Praphan
P
D015492:AIDS Serodiagnosis / Q000191:economics / Q000379:methods*; D003906:Developing Countries; D005260:Female; D015483:HIV Antibodies / Q000378:metabolism*; D015658:HIV Infections / Q000175:diagnosis*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000379:methods*; D015203:Reproducibility of Results; D012463:Saliva / Q000821:virology; D012680:Sensitivity and Specificity; D013997:Time Factors
D015483:HIV Antibodies